TESARO Inc (TSRO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre Partager sur 𝕏

Cours de l'action
Code mnémonique : TSRO Marché : NSM


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette
90 derniers jours
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur totale Détails
2018-03-06 2018-03-02 A Achat

MOTT DAVID M

Large shareholder
17 859 +0.2%
57,34
1 024 114 USD 		17 859 +0.2% 57,34 1 024 114 USD
2018-03-06 2018-03-02 A Achat

MOTT DAVID M

Large shareholder
4 080 +0.0%
56,66
231 174 USD 		4 080 +0.0% 56,66 231 174 USD
2018-03-06 2018-03-02 A Achat

MOTT DAVID M

Large shareholder
6 399 +0.1%
55,01
352 005 USD 		6 399 +0.1% 55,01 352 005 USD
2018-03-06 2018-03-02 A Achat

MOTT DAVID M

Large shareholder
26 304 +0.3%
54,32
1 428 875 USD 		26 304 +0.3% 54,32 1 428 875 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
4 465 +0.6%
57,34
256 043 USD 		4 465 +0.6% 57,34 256 043 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
1 020 +0.1%
56,66
57 794 USD 		1 020 +0.1% 56,66 57 794 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
1 600 +0.2%
55,01
88 015 USD 		1 600 +0.2% 55,01 88 015 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
6 575 +0.9%
54,32
357 165 USD 		6 575 +0.9% 54,32 357 165 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
17 859 +0.2%
57,34
1 024 114 USD 		17 859 +0.2% 57,34 1 024 114 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
4 080 +0.0%
56,66
231 174 USD 		4 080 +0.0% 56,66 231 174 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
6 399 +0.1%
55,01
352 005 USD 		6 399 +0.1% 55,01 352 005 USD
2018-03-06 2018-03-02 A Achat

Viswanathan Ravi

Large shareholder
26 304 +0.3%
54,32
1 428 875 USD 		26 304 +0.3% 54,32 1 428 875 USD
2018-03-06 2018-03-02 A Achat

NEW ENTERPRISE ASSOCIATES 13 LP

Large shareholder
17 859 +0.2%
57,34
1 024 114 USD 		17 859 +0.2% 57,34 1 024 114 USD
2018-03-06 2018-03-02 A Achat

NEW ENTERPRISE ASSOCIATES 13 LP

Large shareholder
4 080 +0.0%
56,66
231 174 USD 		4 080 +0.0% 56,66 231 174 USD
2018-03-06 2018-03-02 A Achat

NEW ENTERPRISE ASSOCIATES 13 LP

Large shareholder
6 399 +0.1%
55,01
352 005 USD 		6 399 +0.1% 55,01 352 005 USD
2018-03-06 2018-03-02 A Achat

NEW ENTERPRISE ASSOCIATES 13 LP

Large shareholder
26 304 +0.3%
54,32
1 428 875 USD 		26 304 +0.3% 54,32 1 428 875 USD
2018-03-06 2018-03-02 A Achat

KERINS PATRICK J

Large shareholder
17 859 +0.2%
57,34
1 024 114 USD 		17 859 +0.2% 57,34 1 024 114 USD
2018-03-06 2018-03-02 A Achat

KERINS PATRICK J

Large shareholder
4 080 +0.0%
56,66
231 174 USD 		4 080 +0.0% 56,66 231 174 USD
2018-03-06 2018-03-02 A Achat

KERINS PATRICK J

Large shareholder
6 399 +0.1%
55,01
352 005 USD 		6 399 +0.1% 55,01 352 005 USD
2018-03-06 2018-03-02 A Achat

KERINS PATRICK J

Large shareholder
26 304 +0.3%
54,32
1 428 875 USD 		26 304 +0.3% 54,32 1 428 875 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
4 465 +0.6%
57,34
256 043 USD 		4 465 +0.6% 57,34 256 043 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
1 020 +0.1%
56,66
57 794 USD 		1 020 +0.1% 56,66 57 794 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
1 600 +0.2%
55,01
88 015 USD 		1 600 +0.2% 55,01 88 015 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
6 575 +0.9%
54,32
357 165 USD 		6 575 +0.9% 54,32 357 165 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
17 859 +0.2%
57,34
1 024 114 USD 		17 859 +0.2% 57,34 1 024 114 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
4 080 +0.0%
56,66
231 174 USD 		4 080 +0.0% 56,66 231 174 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
6 399 +0.1%
55,01
352 005 USD 		6 399 +0.1% 55,01 352 005 USD
2018-03-06 2018-03-02 A Achat

SANDELL SCOTT D

Large shareholder
26 304 +0.3%
54,32
1 428 875 USD 		26 304 +0.3% 54,32 1 428 875 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
4 465 +0.6%
57,34
256 043 USD 		4 465 +0.6% 57,34 256 043 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
1 020 +0.1%
56,66
57 794 USD 		1 020 +0.1% 56,66 57 794 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
1 600 +0.2%
55,01
88 015 USD 		1 600 +0.2% 55,01 88 015 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
6 575 +0.9%
54,32
357 165 USD 		6 575 +0.9% 54,32 357 165 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
17 859 +0.2%
57,34
1 024 114 USD 		17 859 +0.2% 57,34 1 024 114 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
4 080 +0.0%
56,66
231 174 USD 		4 080 +0.0% 56,66 231 174 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
6 399 +0.1%
55,01
352 005 USD 		6 399 +0.1% 55,01 352 005 USD
2018-03-06 2018-03-02 A Achat

BARRIS PETER J

Large shareholder
26 304 +0.3%
54,32
1 428 875 USD 		26 304 +0.3% 54,32 1 428 875 USD
2018-03-05 2018-03-02 VP Vente planifiée

Farmer Joseph L

Sr.VP,Gen.Counsel & Secretary
2 634 -25.1%
54,86
144 501 USD 		2 634 -25.1% 54,86 144 501 USD
2018-03-05 2018-03-02 VP Vente planifiée

Oliveira Orlando

SVP & GM, International
337 -2.7%
54,86
18 488 USD 		337 -2.7% 54,86 18 488 USD
2018-03-05 2018-03-02 VP Vente planifiée

PEARSON TIMOTHY R

Exec. VP, CFO

Dirigeant
2 575 -29.3%
54,86
141 265 USD 		2 575 -29.3% 54,86 141 265 USD
2018-03-05 2018-03-02 A Achat

MOULDER LEON O JR

Chief Executive Officer

Administrateur exécutif
1 000 +25.0%
57,14
57 140 USD 		1 000 +25.0% 57,14 57 140 USD
2018-03-05 2018-03-02 A Achat

MOULDER LEON O JR

Chief Executive Officer

Administrateur exécutif
1 000 +33.3%
56,89
56 890 USD 		1 000 +33.3% 56,89 56 890 USD
2018-03-05 2018-03-02 A Achat

MOULDER LEON O JR

Chief Executive Officer

Administrateur exécutif
1 000 +50.0%
56,88
56 880 USD 		1 000 +50.0% 56,88 56 880 USD
2018-03-05 2018-03-02 A Achat

MOULDER LEON O JR

Chief Executive Officer

Administrateur exécutif
1 000 +100.0%
56,87
56 870 USD 		1 000 +100.0% 56,87 56 870 USD
2018-03-05 2018-03-02 A Achat

MOULDER LEON O JR

Chief Executive Officer

Administrateur exécutif
1 000 +inf%
56,86
56 860 USD 		1 000 +inf% 56,86 56 860 USD
2018-03-05 2018-03-02 VP Vente planifiée

Huber Martin H. Jr.

SVP & Chief Medical Officer

Dirigeant
1 803 -13.7%
54,86
98 913 USD 		1 803 -13.7% 54,86 98 913 USD
2018-03-05 2018-03-01 VP Vente planifiée

Hedley Mary Lynne

President & COO

Administrateur exécutif
3 855 -20.4%
54,86
211 485 USD 		3 855 -20.4% 54,86 211 485 USD
2018-03-05 2018-03-01 VP Vente planifiée

Bogle Grant C.

Sr. VP, Chief Commercial Ofc.

Dirigeant
1 809 -29.0%
54,85
99 224 USD 		1 809 -29.0% 54,85 99 224 USD
2017-12-05 2017-12-04 V Vente

Huber Martin H. Jr.

SVP & Chief Medical Officer
829 -10.2%
85,24
70 664 USD 		829 -10.2% 85,24 70 664 USD
2017-09-25 2017-09-22 VP Vente planifiée

Huber Martin H. Jr.

SVP & Chief Medical Officer
592 -8.5%
118,60
70 211 USD 		592 -8.5% 118,60 70 211 USD
2017-09-20 2017-09-18 VP Vente planifiée

Armitage James O

5 743 -100.0%
117,58
675 262 USD 		5 743 -100.0% 117,58 675 262 USD
2017-09-20 2017-09-18 VP Vente planifiée

Armitage James O

4 257 -42.6%
116,52
496 026 USD 		4 257 -42.6% 116,52 496 026 USD
2017-09-06 2017-09-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
300 -43.1%
136,26
40 878 USD 		300 -43.1% 136,26 40 878 USD
2017-09-06 2017-09-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
5 102 -88.0%
135,40
690 811 USD 		5 102 -88.0% 135,40 690 811 USD
2017-09-06 2017-09-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
5 460 -48.5%
134,39
733 769 USD 		5 460 -48.5% 134,39 733 769 USD
2017-09-06 2017-09-05 V Vente

Oliveira Orlando

SVP & GM, International
71 -1.1%
132,66
9 419 USD 		71 -1.1% 132,66 9 419 USD
2017-09-06 2017-09-01 VP Vente planifiée

Bogle Grant C.

Sr. VP, Chief Commercial Ofc.
14 167 -98.0%
135,00
1 912 545 USD 		14 167 -98.0% 135,00 1 912 545 USD
2017-06-08 2017-06-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
362 -47.8%
142,16
51 462 USD 		362 -47.8% 142,16 51 462 USD
2017-06-08 2017-06-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
638 -45.7%
140,05
89 352 USD 		638 -45.7% 140,05 89 352 USD
2017-06-08 2017-06-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
3 400 -70.9%
138,82
471 988 USD 		3 400 -70.9% 138,82 471 988 USD
2017-06-08 2017-06-06 VP Vente planifiée

English Edward C

VP of Finance & Administration
4 100 -46.1%
137,98
565 718 USD 		4 100 -46.1% 137,98 565 718 USD
2017-04-04 2017-04-03 V Vente

Huber Martin H. Jr.

SVP & Cheif Medical Officer
829 -12.7%
153,02
126 854 USD 		829 -12.7% 153,02 126 854 USD
2017-03-08 2017-03-06 VP Vente planifiée

English Edward C

V.P. of Finance & Admin.
10 000 -96.2%
178,06
1 780 600 USD 		10 000 -96.2% 178,06 1 780 600 USD
2017-03-03 2017-03-02 VP Vente planifiée

PEARSON TIMOTHY R

Exec. VP, CFO
1 447 -33.1%
177,61
257 002 USD 		1 447 -33.1% 177,61 257 002 USD
2017-03-03 2017-03-02 VP Vente planifiée

Bogle Grant C.

Sr VP,Chief Commercial Officer
1 447 -31.4%
177,61
257 002 USD 		1 447 -31.4% 177,61 257 002 USD
2017-03-03 2017-03-02 VP Vente planifiée

Huber Martin H. Jr.

Sr. VP, Chief Medical Officer
1 428 -23.0%
177,61
253 627 USD 		1 428 -23.0% 177,61 253 627 USD
2017-03-03 2017-03-02 VP Vente planifiée

English Edward C

VP of Finance & Administration
229 -36.6%
177,61
40 673 USD 		229 -36.6% 177,61 40 673 USD
2017-03-03 2017-03-02 VP Vente planifiée

Oliveira Orlando

SVP & GM, International
249 -4.4%
177,61
44 225 USD 		249 -4.4% 177,61 44 225 USD
2017-03-03 2017-03-02 VP Vente planifiée

Farmer Joseph L

Sr VP,Gen. Counsel & Secretary
1 449 -27.5%
177,61
257 357 USD 		1 449 -27.5% 177,61 257 357 USD
2017-03-03 2017-03-02 VP Vente planifiée

Hedley Mary Lynne

President & COO

Administrateur exécutif
3 927 -39.3%
177,61
697 474 USD 		3 927 -39.3% 177,61 697 474 USD
2017-01-03 2017-01-03 V Vente

Huber Martin H. Jr.

SVP & Chief Medical Officer
190
136,26
25 889 USD 		190 136,26 25 889 USD
2016-12-14 2016-12-12 VP Vente planifiée

English Edward C

VP of Finance and Admin.

Dirigeant
8 300 -100.0%
129,20
1 072 360 USD 		8 300 -100.0% 129,20 1 072 360 USD
2016-12-14 2016-12-12 VP Vente planifiée

English Edward C

VP of Finance and Admin.

Dirigeant
1 700 -17.0%
128,30
218 110 USD 		1 700 -17.0% 128,30 218 110 USD
2016-11-03 2016-11-02 V Vente

Huber Martin H. Jr.

SVP & Chief Medical Officer

Dirigeant
327 -17.8%
121,29
39 662 USD 		327 -17.8% 121,29 39 662 USD
2016-09-23 2016-09-22 VP Vente planifiée

Huber Martin H. Jr.

SVP & Chief Medical Officer

Dirigeant
408 -32.6%
108,12
44 113 USD 		408 -32.6% 108,12 44 113 USD
2016-09-09 2016-09-08 VP Vente planifiée

English Edward C

V.P.Finance and Administration

Dirigeant
1 500 -100.0%
90,47
135 705 USD 		1 500 -100.0% 90,47 135 705 USD